U.S. Markets closed
  • S&P 500

    4,008.02
    -15.87 (-0.39%)
     
  • Dow 30

    32,223.42
    +26.76 (+0.08%)
     
  • Nasdaq

    11,662.79
    -142.21 (-1.20%)
     
  • Russell 2000

    1,785.28
    -7.38 (-0.41%)
     
  • Crude Oil

    114.01
    +3.52 (+3.19%)
     
  • Gold

    1,825.10
    +16.90 (+0.93%)
     
  • Silver

    21.67
    +0.67 (+3.19%)
     
  • EUR/USD

    1.0433
    +0.0016 (+0.1565%)
     
  • 10-Yr Bond

    2.8770
    -0.0580 (-1.98%)
     
  • Vix

    27.75
    -1.12 (-3.88%)
     
  • GBP/USD

    1.2316
    +0.0054 (+0.4385%)
     
  • USD/JPY

    129.0830
    -0.1020 (-0.0790%)
     
  • BTC-USD

    29,596.10
    -821.46 (-2.70%)
     
  • CMC Crypto 200

    663.53
    +420.85 (+173.42%)
     
  • FTSE 100

    7,464.80
    +46.65 (+0.63%)
     
  • Nikkei 225

    26,547.05
    +119.40 (+0.45%)
     

Malaysia to buy Pfizer COVID-19 vaccine for children aged 5 to 11

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

KUALA LUMPUR, Oct 29 (Reuters) - Malaysia said on Friday it would proceed with the procurement of the Pfizer Inc and BioNTech COVID-19 vaccine for children, following a U.S. expert panel's recommendation for the shot to be authorised for those aged 5 to 11.

A panel of advisers to the U.S. Food and Drug Administration voted on Tuesday to recommend the authorisation, saying the benefits of the vaccine outweigh the risks. The agency's decision is still pending.

Malaysia's Health Minister Khairy Jamaluddin said on Twitter other options, such as the vaccine made by China's Sinovac BioTech, would also be considered to ensure schools can reopen safely.

About 62% of teenagers aged between 12 and 17 in the Southeast Asian country are fully vaccinated, government statistics showed on Friday. (Reporting by Rozanna Latiff Editing by James Pearson)